Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Budi Starch Sweetener Tbk (BUDI) vs UBC Medical Indonesia Tbk. (LABS)

Budi Starch Sweetener TbkTrading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Budi Starch Sweetener Tbk dan UBC Medical Indonesia Tbk.: Budi Starch Sweetener Tbk diperdagangkan di Rp220 (kapitalisasi pasar 980,78 M, volume 24 jam 483 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: Budi Starch Sweetener Tbk lebih besar dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (843 rb vs 483 rb). Mana yang lebih baik tergantung tujuan investasimu.

BUDILABS
Kapitalisasi Pasar
980,78 M635,95 M
Volume
483 rb843 rb
Lot
4,83 rb8,43 rb
Perputaran
107,13 jt137,6 jt
Harga Rata-rata
221,8163,22
Nilai Transaksi
107,13 jt137,6 jt
Harga Ekuilibrium Indikatif
224165
Volume Ekuilibrium Indikatif
12246

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BUDI
Lihat detail
LABS
Lihat detail

Tentang Budi Starch Sweetener Tbk

PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.

Selengkapnya di halaman BUDI

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS